C5AR2 and breast carcinoma: Strong correlations were shown between elevated C5AR2 expression and poorer prognosis in BRCA (ER-positive), indicating that C5AR2 has a malignant biological character as well as specific prognostic value, and it may be an oncogene in breast cancer.